Monopar Therapeutics Inc.
MNPR
$80.13
-$2.43-2.94%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 6.53% | 75.97% | -737.66% | 23.96% | -4.51% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -5.57% | -71.95% | 2,326.37% | -40.46% | 1.73% |
Change in Net Operating Assets | 102.20% | -207.25% | 12,822.08% | 110.71% | 13.71% |
Cash from Operations | 80.98% | -183.39% | -86.16% | 35.98% | -1.29% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 464.43% | 97.73% | -1,554.64% | 41,170.83% | 99.76% |
Cash from Investing | 464.43% | 97.73% | -1,554.64% | 41,170.83% | 99.76% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -69.48% | -99.97% | -- | -100.00% | -100.00% |
Repurchase of Common Stock | -145.31% | -95.96% | -305.45% | -65.00% | 6.54% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -173.81% | -100.21% | 340,323.03% | -66.67% | -100.31% |
Foreign Exchange rate Adjustments | -2,500.00% | 97.37% | -184.44% | 200.00% | 188.24% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 96.57% | -115.34% | 39,975.95% | 94.09% | -411.65% |